Gastrointestinal Cancer Research Laboratory, Baylor University Medical Center, Dallas, TX, USA.
Int J Cancer. 2011 Feb 15;128(4):869-78. doi: 10.1002/ijc.25422.
Lynch syndrome is an autosomal dominant cancer predisposition syndrome classically caused by germline mutations of the mismatch repair genes, MLH1, MSH2, MSH6 and PMS2. Constitutional epimutations of the MLH1 gene, characterized by soma-wide methylation of a single allele of the promoter and allelic transcriptional silencing, have been identified in a subset of Lynch syndrome cases lacking a sequence mutation in MLH1. We report two individuals with no family history of colorectal cancer who developed that disease at age 18 and 20 years. In both cases, cancer had arisen because of the de novo occurrence of a constitutional MLH1 epimutation and somatic loss-of-heterozygosity of the functional allele in the tumors. We show for the first time that the epimutation in one case arose on the paternally inherited allele. Analysis of 13 tumors from seven individuals with constitutional MLH1 epimutations showed eight tumors had lost the second MLH1 allele, two tumors had a novel pathogenic missense mutation and three had retained heterozygosity. Only 1 of 12 tumors demonstrated the BRAF V600E mutation and 3 of 11 tumors harbored a mutation in KRAS. The finding that epimutations can originate on the paternal allele provides important new insights into the mechanism of origin of epimutations. It is clear that the second hit in MLH1 epimutation-associated tumors typically has a genetic not epigenetic basis. Individuals with mismatch repair-deficient cancers without the BRAF V600E mutation are candidates for germline screening for sequence or methylation changes in MLH1.
林奇综合征是一种常染色体显性遗传的癌症易感性综合征,经典地由错配修复基因(MLH1、MSH2、MSH6 和 PMS2)的种系突变引起。MLH1 基因的结构内表观突变,其特征是启动子的单个等位基因的广泛甲基化和等位基因转录沉默,已在缺乏 MLH1 序列突变的林奇综合征病例亚组中被鉴定出来。我们报告了两例无结直肠癌家族史的个体,他们在 18 岁和 20 岁时患上了这种疾病。在这两种情况下,由于肿瘤中功能性等位基因的从头发生的结构 MLH1 表观突变和体细胞杂合性丢失,癌症已经发生。我们首次表明,一个病例中的表观突变发生在父系遗传的等位基因上。对 7 例具有结构 MLH1 表观突变的个体的 13 个肿瘤进行分析表明,8 个肿瘤失去了第二个 MLH1 等位基因,2 个肿瘤有新的致病性错义突变,3 个肿瘤保留了杂合性。只有 12 个肿瘤中的 1 个显示 BRAF V600E 突变,11 个肿瘤中的 3 个携带 KRAS 突变。发现表观突变可以起源于父系等位基因,为表观突变起源的机制提供了重要的新见解。显然,MLH1 表观突变相关肿瘤中的第二次打击通常具有遗传而非表观遗传学基础。没有 BRAF V600E 突变的错配修复缺陷癌症个体是进行 MLH1 序列或甲基化改变种系筛查的候选者。